Australian researchers achieve a breakthrough in improving breast cancer cure rates, offering new hope for patients worldwide.
Vous n'êtes pas connecté
In breast cancer patients, adding the immunotherapy drug nivolumab to pre-surgery chemotherapy can significantly enhance patient outcomes, as highlighted
Australian researchers achieve a breakthrough in improving breast cancer cure rates, offering new hope for patients worldwide.
BriaCell (TSX:BCT) reports that the first metastatic breast cancer patient treated with its Bria-OTS drug is now cancer-free in the lungs.
A new study has found a way to treat patients with triple-negative breast cancer using a shorter and less toxic treatment plan while achieving similar...
Lung-sparing surgery could enhance outcomes for early-stage lung cancer patients by preserving lung function while effectively treating the disease.
Data analysis from a randomised clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center, USA, found...
Study finds too few women are told chemotherapy can cause early menopause – or given the drug that can lessen that risk
Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for monitoring patient outcomes.
Weill Cornell Medicine, USA, has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable...
Researchers at the University of Pittsburgh have discovered a groundbreaking method to grow T cells in the lab that not only extends their lifespan...
FRIDAY, Jan. 24, 2025 -- Patients can improve their odds for a successful surgery by actively preparing for the procedure through diet and exercise, a...